152 related articles for article (PubMed ID: 25340261)
41. Design and characterization of Amoitone B-loaded nanostructured lipid carriers for controlled drug release.
Luan J; Zhang D; Hao L; Li C; Qi L; Guo H; Liu X; Zhang Q
Drug Deliv; 2013 Nov; 20(8):324-30. PubMed ID: 24032657
[TBL] [Abstract][Full Text] [Related]
42. Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study.
Madane RG; Mahajan HS
Drug Deliv; 2016 May; 23(4):1326-34. PubMed ID: 25367836
[TBL] [Abstract][Full Text] [Related]
43. Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicity.
How CW; Rasedee A; Manickam S; Rosli R
Colloids Surf B Biointerfaces; 2013 Dec; 112():393-9. PubMed ID: 24036474
[TBL] [Abstract][Full Text] [Related]
44. Quality by design approach to understand the process of optimization of iloperidone nanostructured lipid carriers for oral bioavailability enhancement.
Mandpe L; Pokharkar V
Pharm Dev Technol; 2015 May; 20(3):320-9. PubMed ID: 24328553
[TBL] [Abstract][Full Text] [Related]
45. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.
Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G
Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497
[TBL] [Abstract][Full Text] [Related]
46. Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application.
Pardeike J; Weber S; Haber T; Wagner J; Zarfl HP; Plank H; Zimmer A
Int J Pharm; 2011 Oct; 419(1-2):329-38. PubMed ID: 21839157
[TBL] [Abstract][Full Text] [Related]
47. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.
Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N
Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882
[TBL] [Abstract][Full Text] [Related]
48. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
[TBL] [Abstract][Full Text] [Related]
49. Lipid nanoparticles as carrier for octyl-methoxycinnamate: in vitro percutaneous absorption and photostability studies.
Puglia C; Bonina F; Rizza L; Blasi P; Schoubben A; Perrotta R; Tarico MS; Damiani E
J Pharm Sci; 2012 Jan; 101(1):301-11. PubMed ID: 21905033
[TBL] [Abstract][Full Text] [Related]
50. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers.
Jia L; Shen J; Zhang D; Duan C; Liu G; Zheng D; Tian X; Liu Y; Zhang Q
Int J Biol Macromol; 2012 Apr; 50(3):523-9. PubMed ID: 22301003
[TBL] [Abstract][Full Text] [Related]
51. Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment.
Neupane YR; Srivastava M; Ahmad N; Kumar N; Bhatnagar A; Kohli K
Int J Pharm; 2014 Dec; 477(1-2):601-12. PubMed ID: 25445972
[TBL] [Abstract][Full Text] [Related]
52. [Preparation and in vitro characterization of apigemin-loaded nanostructured lipid carriers].
Zhai YJ; Guo CY; Hou JN; Zhang WD; Zhai GX
Zhong Yao Cai; 2011 Jun; 34(6):962-5. PubMed ID: 22017012
[TBL] [Abstract][Full Text] [Related]
53. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
[TBL] [Abstract][Full Text] [Related]
54. Arteether nanoemulsion for enhanced efficacy against Plasmodium yoelii nigeriensis malaria: an approach by enhanced bioavailability.
Dwivedi P; Khatik R; Chaturvedi P; Khandelwal K; Taneja I; Raju KS; Dwivedi H; Singh SK; Gupta PK; Shukla P; Tripathi P; Singh S; Tripathi R; Wahajuddin ; Paliwal SK; Dwivedi AK; Mishra PR
Colloids Surf B Biointerfaces; 2015 Feb; 126():467-75. PubMed ID: 25616971
[TBL] [Abstract][Full Text] [Related]
55. Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release.
Souza LG; Silva EJ; Martins AL; Mota MF; Braga RC; Lima EM; Valadares MC; Taveira SF; Marreto RN
Eur J Pharm Biopharm; 2011 Sep; 79(1):189-96. PubMed ID: 21352915
[TBL] [Abstract][Full Text] [Related]
56. Preparation and characteristics of monostearin nanostructured lipid carriers.
Hu FQ; Jiang SP; Du YZ; Yuan H; Ye YQ; Zeng S
Int J Pharm; 2006 May; 314(1):83-9. PubMed ID: 16563671
[TBL] [Abstract][Full Text] [Related]
57. Artesunate-loaded chitosan/lecithin nanoparticles: preparation, characterization, and in vivo studies.
Chadha R; Gupta S; Pathak N
Drug Dev Ind Pharm; 2012 Dec; 38(12):1538-46. PubMed ID: 22348223
[TBL] [Abstract][Full Text] [Related]
58. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier.
Beloqui A; Solinís MÁ; Gascón AR; del Pozo-Rodríguez A; des Rieux A; Préat V
J Control Release; 2013 Mar; 166(2):115-23. PubMed ID: 23266764
[TBL] [Abstract][Full Text] [Related]
59. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
[TBL] [Abstract][Full Text] [Related]
60. Preparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriers.
Luan J; Zhang D; Hao L; Qi L; Liu X; Guo H; Li C; Guo Y; Li T; Zhang Q; Zhai G
Colloids Surf B Biointerfaces; 2014 Feb; 114():255-60. PubMed ID: 24211416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
